畜牧兽医学报 ›› 2026, Vol. 57 ›› Issue (1): 327-336.doi: 10.11843/j.issn.0366-6964.2026.01.028

• 预防兽医 • 上一篇    下一篇

gD基因插入增强gI/gE/gM缺失重组伪狂犬病病毒对小鼠的免疫效果

陆灵光(), 刘家齐(), 卢佩琪, 吴瑞彬, 黄丹妮, 刘佳悦, 梁婉琪, 琚春梅()   

  1. 华南农业大学兽医学院 广东省动物源性人兽共患病预防与控制重点实验室,广州 510642
  • 收稿日期:2024-11-08 出版日期:2026-01-23 发布日期:2026-01-26
  • 通讯作者: 琚春梅 E-mail:lulingguang0401@163.com;ljq18853852097@163.com;juchunmei@scau.edu.cn
  • 作者简介:陆灵光,博士生,主要从事病毒致病机制与防控研究,E-mail:lulingguang0401@163.com
    刘家齐,硕士生,主要从事病毒致病机制与防控研究,E-mail:ljq18853852097@163.com
    第一联系人:陆灵光和刘家齐为同等贡献作者
  • 基金资助:
    国家重点研发计划项目(2022YFD1800100)

Immune Effect of gD Gene Insertion-enhanced gI/gE/gM Deleted Recombinant Pseudorabies Virus in Mice

LU Lingguang(), LIU Jiaqi(), LU Peiqi, WU Ruibin, HUANG Danni, LIU Jiayue, LIANG Wanqi, JU Chunmei()   

  1. Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,China
  • Received:2024-11-08 Online:2026-01-23 Published:2026-01-26
  • Contact: JU Chunmei E-mail:lulingguang0401@163.com;ljq18853852097@163.com;juchunmei@scau.edu.cn

摘要:

本研究旨在构建双拷贝gD基因的重组伪狂犬病病毒rPRV-AH-gI-/gE-/gM-/gD+,并对其免疫效力进行评价。以rPRV-AH-gI-/gE-为亲本毒株,利用同源重组技术,缺失gM基因并在其缺失位置插入PRV gD基因表达盒,构建重组病毒rPRV-AH-gI-/gE-/gM-/gD+。用107.0 TCID50 的rPRV-AH-gI-/gE-、rPRV-AH-gI-/gE-/gM-、rPRV-AH-gI-/gE-/gM-/gD+制备灭活疫苗,免疫4周龄昆明小鼠2次,间隔3周,并设商品化疫苗和DMEM对照组,免疫后定期采血,通过中和试验检测小鼠血清中和抗体水平,ELISA试验检测小鼠血清总抗体水平,在首免后6周用105.5 TCID50 PRV-AH进行攻毒试验。结果显示:rPRV-AH-gI-/gE-/gM-/gD+中插入的gD基因获得了表达,表达蛋白大小约为53 ku;rPRV-AH-gI-/gE-/gM-/gD+组小鼠在首免后4、6周中和抗体及血清总IgG抗体水平均显著高于rPRV-AH-gI-/gE-、rPRV-AH-gI-/gE-/gM-组(P<0.01),但与商品化疫苗组相比差异不显著(P>0.05);用PRV-AH攻毒后,rPRV-AH-gI-/gE-/gM-/gD+、rPRV-AH-gI-/gE-/gM-、rPRV-AH-gI-/gE-和商品化疫苗组的攻毒保护率分别为100%、70%、60%和90%。综上表明,gD基因的插入可以提高重组病毒的免疫保护效果,为PRV流行毒株候选疫苗的研制奠定了一定的基础。

关键词: 伪狂犬病病毒, 双拷贝gD, 同源重组, 免疫效力

Abstract:

In this study, we aimed to develop recombinant PRV rPRV-AH-gI-/gE-/gM-/gD+ with double gD and evaluate its immune efficacy. The recombinant virus rPRV-AH-gI-/gE-/gM-/gD+ was constructed by deleting gM gene and inserting gD expression cassette at the deficient region. Four-week-old Kunming mice were immunized twice with 107.0 TCID50 inactivated rPRV-AH-gI-/gE-, rPRV-AH-gI-/gE-/gM-, rPRV-AH-gI-/gE-/gM-/gD+ at an interval of 3 weeks. Commercial vaccine and DMEM were as the control group. After immunization, regular blood was collected, neutralizing antibody levels in sera were detected by neutralization test, and total antibody levels were detected by ELISA. At 6 weeks of first immunization, mice were challenged with 105.5TCID50 PRV-AH. The inserted gD gene was expressed with the molecular weight of 53 ku in the rPRV-AH-gI-/gE-/gM-/gD+. The neutralizing and total IgG antibody levels of rPRV-AH-gI-/gE-/gM-/gD+ group were significantly higher than those of rPRV-AH-gI-/gE and rPRV-AH-gI-/gE-/gM- at 4 and 6 weeks after first immunization (P<0.01). However, compared with the commercial vaccine group, the difference was not significant (P>0.05). After challenged with PRV-AH, the protection rates were 100%, 70%, 60% and 90% of the rPRV-AH-gI-/gE-/gM-/gD+, rPRV-AH-gI-/gE-/gM-, rPRV-AH-gI-/gE- and commercial vaccine groups respectively. The results showed that the insertion of gD gene can improve the immune protection effect of the recombinant virus which is helpful in developing vaccine candidate for PRV control.

Key words: pseudorabies virus, double gD, homologous recombination, immune efficacy

中图分类号: